Don't put foreign pharmaceutical price controls on a pedestal
Last updated 6/6/2019 at 8:25am
President Trump vowed to expand patient access to prescription drugs on the campaign trail. But with one proposal, his administration seems to be working against this goal.
The Department of Health and Human Services recently unveiled a plan to impose artificial price controls on the advanced, physician-administered drugs covered under Medicare Part B.
While the proposal could trim government spending, it will reduce access to medicine and devastate innovation. The president should reconsider.
It’s no surprise that HHS wants to tackle drug spending. In 2016, the government spent over $2...